Estrella Immunopharma, Inc. (ESLAW) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$10.37M | -7312.1% |
| 2024 | $143.7K | +101.2% |
| 2023 | -$11.74M | -420.6% |
| 2022 | -$2.26M | -124.2% |
| 2021 | -$1.01M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$10.37M | -7312.1% |
| 2024 | $143.7K | +101.2% |
| 2023 | -$11.74M | -420.6% |
| 2022 | -$2.26M | -124.2% |
| 2021 | -$1.01M | — |